Virax Biolabs Group Limited (VRAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2021 | 03-2021 | 12-2020 | 03-2020 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -673 | N/A | N/A | N/A |
| Accounts receivable | N/A | -1 | N/A | N/A | N/A |
| Other Working Capital | N/A | 60 | N/A | N/A | N/A |
| Other Operating Activity | 0 | 24 | 0 | 0 | 0 |
| Operating Cash Flow | $N/A | $-590 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 403 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 182 | 0 | 0 | 0 |
| Financing Cash Flow | $N/A | $585 | $N/A | $N/A | $N/A |
| Beginning Cash Position | N/A | 23 | N/A | N/A | N/A |
| End Cash Position | N/A | 18 | N/A | N/A | N/A |
| Net Cash Flow | $N/A | $-5 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -590 | N/A | N/A | N/A |
| Free Cash Flow | 0 | -590 | 0 | 0 | 0 |